.webp)
Experience in implant dentistry is not just a number of years. It is the accumulation of case types, complications encountered and managed, protocols refined, and outcomes followed up over time. At Dazzle Dental Clinic, our All-on-4 experience is best understood through what it has taught us about how the protocol performs across different patient populations — and how our clinical approach has evolved as a result.
What 10,000+ Implants Placed Actually Means
Dazzle has placed over 10,000 implants across more than two decades of practice, including full-arch All-on-4 and All-on-6 cases, zygomatic implants, and complex multi-stage rehabilitations. Volume at this level means the clinical team has encountered the full distribution of bone quality, anatomical variation, healing complications, and prosthetic challenges — not just the straightforward cases that any moderately busy practice accumulates.
More specifically: our team has managed All-on-4 cases in Misch Type I through Type IV bone, in patients with previous implant failures, in patients with uncontrolled diabetes brought into controlled range before surgery, in patients who smoke, and in patients with zygomatic anatomy that required individualised planning. The outcome data from these cases — which we follow at 1, 3, 5, and where possible 10 years post-placement — informs our current protocols.
This history also means we have an honest reckoning with failure. Implant failures happen at the clinical population level even in excellent hands. Our 10-year implant survival rate for All-on-4 cases aligns with published literature at 95–98%. The 2–5% that do not reach 10 years are almost entirely concentrated in high-risk patient groups — uncontrolled systemic disease, active smoking, inadequate primary stability that was accepted when it should not have been. This clinical knowledge shapes our pre-surgical assessment and our honest candidacy conversations.
International Training and Protocol Currency
Dazzle’s implantologists train with Nobel Biocare — the organisation that developed and continues to develop the All-on-4 protocol through Paulo Maló’s original clinical programme. This training is not a credential to display; it is access to the current protocol evolution. All-on-4 surgical protocol has changed meaningfully over 20 years: primary stability thresholds have been refined, prosthetic design principles have evolved, biomaterial choices have changed. Training through the originating institution means our protocols reflect current evidence rather than what was standard when we began.
Our team also participates in international implantology congresses (ITI, EAO, ICOI) and peer-reviewed study clubs, which provide exposure to outcome data beyond our own case series. Protocol decisions at Dazzle are informed by the global published evidence base, not only by our own clinical experience.
Patients from 20+ Countries: What International Volume Requires
Treating patients from the UK, UAE, Australia, East Africa, and across India at significant volume requires clinical systems that conventional dental practice does not need. Remote case assessment (reviewing CBCT scans before the patient travels), treatment planning that accounts for a compressed visit schedule, prosthetic workflows that deliver the final bridge within a defined return visit window, and post-treatment documentation that enables a local dentist to continue maintenance — all of these are operational capabilities developed through years of managing international patients rather than marketing claims.
The outcome implications are real: a clinic that regularly manages international patients has stronger incentive to get the surgical and prosthetic plan right before the patient arrives, because intraoperative surprises are more consequential when the patient cannot return easily. This external accountability to remote patients has tightened our pre-surgical planning discipline in ways that benefit all patients.
In-House Digital Laboratory: What It Changes
Our in-house digital laboratory means that the distance between a prosthetic design decision and its physical execution is hours, not weeks. The clinical team and lab technician are in the same building. When the try-in reveals a contour that needs adjustment, the modification is made that day. This compression of the design-fabrication-delivery cycle is most significant for international patients managing a fixed visit window, but it also improves outcome quality for all patients through faster iteration.
FAQs
Q1: How many All-on-4 cases does Dazzle perform per year?
Full-arch implant cases (All-on-4, All-on-6, and zygomatic combinations) represent a significant proportion of Dazzle’s surgical volume. We do not publish specific annual case numbers publicly, but the clinical team’s operating frequency is consistent with a high-volume specialist implant practice rather than a general dental clinic with occasional implant cases.
Q2: What happens if my implant fails after I return home?
Individual implant failures in the osseointegration phase are uncommon but do occur. Our protocol for remote patients includes a 3-month review window during which re-assessment is expected. If an implant fails, we coordinate replacement planning, which in most cases can be managed on the same return visit schedule as the final prosthesis appointment. The specific protocol is discussed at consultation and documented in the treatment plan.
Q3: Can I see before-and-after cases from Dazzle’s All-on-4 patients?
Yes. Our gallery includes documented cases with pre-treatment, provisional, and final prosthesis photographs. We also have radiographic case records showing bone levels at baseline, 6-month review, and annual follow-up for selected cases. These are available to review at consultation.
Q4: What is the difference between 10,000 implants placed and 10,000 successful implants?
An honest distinction. We have placed over 10,000 implants. The survival rate at 10 years for the protocol and patient population we treat aligns with published literature at 95–98%. The number placed is a volume metric; the survival rate is the clinical quality metric. Both matter.
